0001209191-20-018918.txt : 20200313
0001209191-20-018918.hdr.sgml : 20200313
20200313165303
ACCESSION NUMBER: 0001209191-20-018918
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200311
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schneider Joel Solomon Zev
CENTRAL INDEX KEY: 0001727649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 20713539
MAIL ADDRESS:
STREET 1: C/O SOLID BIOSCIENCES, LLC
STREET 2: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 900943402
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-337-4680
MAIL ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-11
0
0001707502
Solid Biosciences Inc.
SLDB
0001727649
Schneider Joel Solomon Zev
C/O SOLID BIOSCIENCES INC.
141 PORTLAND STREET, 5TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Technology Officer
Common Stock
2020-03-11
4
A
0
75000
0.00
A
201656
D
The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.
/s/ by Lynette Herscha as attorney-in-fact for Joel Schneider
2020-03-13